Category: testosterone
In Australia, is Addyi (Flibanserin) available or what is available?
Australia Leads the Way in Androgen Treatment for Women with HSDD While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s… Continue Reading →
MHRA approves testosterone cream for UK postmenopausal women
MHRA approves testosterone cream for UK postmenopausal women 12 August 2025 Perth, Australia and Guildford, England: Lawley Pharmaceuticals and its commercial… Continue Reading →
NEW IMS Symposium with Dr James Simon & Sharon Parish
Sexual Health and Treatment for Women: Fact, Fiction, the Future. At the International Menopause Society’s 19th World Congress on Menopause to be held 19th – 22nd October 2024 in… Continue Reading →
BMS: Menopause: Misinformation and Management
The conversation around menopause is getting louder but there is still a lot of misinformation. British Menopause Society medical professionals dispel menopause misinformation, talk… Continue Reading →
World Menopause Day – 18th October
The theme for World Menopause Day 2023 is Cardiovascular Disease World Menopause Day is held every year on the 18th October. The purpose of the… Continue Reading →
In Australia, is Addyi (Flibanserin) available or what is available?
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months. The United States Food and Drug Administration (FDA) approved the… Continue Reading →
Monash University – New study to see whether a skin cream can prevent heart failure in women
Find A Doctor Who Knows Menopause
Find an AMS doctor To help you find a doctor who is right for you, the AMS has assembled this search feature of AMS… Continue Reading →
AndroFeme 1 licensed for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals has obtained approval for registration of AndroFeme® 1 in the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →